Anzeige
Mehr »
Login
Samstag, 31.07.2021 Börsentäglich über 12.000 News von 667 internationalen Medien
Patent-Riese schlägt zu! Auffällige Volumina ziehen Käufer an! Aktie geht steil!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 120159 ISIN: US64049M2098 Ticker-Symbol: NG9 
Tradegate
29.07.21
13:36 Uhr
38,110 Euro
+0,150
+0,40 %
1-Jahres-Chart
NEOGENOMICS INC Chart 1 Jahr
5-Tage-Chart
NEOGENOMICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
39,04039,84012:39
38,60039,14030.07.

Aktuelle News zur NEOGENOMICS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14.07.NeoGenomics, Inc.: NeoGenomics Schedules its Second Quarter 2021 Earnings Release for August 6, 2021429FT. MYERS, FL / ACCESSWIRE / July 14, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans...
► Artikel lesen
07.07.NEOGENOMICS INC - 8-K, Current Report2
02.07.NeoGenomics: Strong Growth Potential For A Leader In Cancer Diagnostic Testing5
NEOGENOMICS Aktie jetzt für 0€ handeln
24.06.NeoGenomics a new best idea long at Hedgeye, sees path to $80/share4
21.06.Schroder UK PublicPT: NeoGenomics completes Inivata acquisition-
18.06.NeoGenomics completes Inivata acquisition-
18.06.NeoGenomics, Inc.: NeoGenomics Completes Inivata Acquisition - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform246Acquisition establishes NeoGenomics as a technology leader in the minimal residual disease (MRD) testing marketFT. MYERS, FL / ACCESSWIRE / June 18, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading...
► Artikel lesen
08.06.NEOGENOMICS INC - 8-K, Current Report2
02.06.NEOGENOMICS INC - S-8, Securities to be offered to employees in employee benefit plans1
27.05.NeoGenomics, Inc.: NeoGenomics To Participate Virtually In Multiple Upcoming Institutional Investor Conferences348FT MYERS, FL / ACCESSWIRE / May 27, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced...
► Artikel lesen
18.05.Artisan Remains Optimistic on the Longer-Term Profit Cycle Potential of NeoGenomics (NEO)2
10.05.NeoGenomics, Inc.: NeoGenomics To Participate In The Bank of America 2021 Health Care Conference334FT. MYERS, FL / ACCESSSWIRE / May 10, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced...
► Artikel lesen
06.05.NEOGENOMICS INC - 10-Q, Quaterly Report1
06.05.NeoGenomics to acquire Inivata for $390M after success of lung cancer liquid biopsy collab1
06.05.NeoGenomics, Inc. 2021 Q1 - Results - Earnings Call Presentation1
06.05.NeoGenomics (NEO) CEO Mark Mallon on Q1 2021 Results - Earnings Call Transcript3
05.05.NeoGenomics Exercises Option To Acquire Remaining Stake In Inivata For $390M3
05.05.The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues11
05.05.NEOGENOMICS INC - 8-K, Current Report1
05.05.NeoGenomics, Inc.: NeoGenomics Reports 9% Revenue Growth to $116 Million in the First Quarter222First-Quarter 2021 Results and Highlights: Consolidated revenue increased 9% to $116 million Clinical Services revenue increased 4% to $96 million Pharma Services revenue increased 46% to $19...
► Artikel lesen
Seite:  Weiter >>
58 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,3